Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Rigel Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rigel Pharmaceuticals Inc. May 14, 202686.2%
-
NeoGenomics Inc. May 22, 202598.9%
-
NeoGenomics Inc. May 23, 2024100.0%
-
NeoGenomics Inc. May 25, 2023100.0%
-
Rigel Pharmaceuticals Inc. May 25, 202378.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +24,400 | — | — |
| May 15, 2026 | Rigel Pharmaceuticals Inc. | Grant or award | +5,750 | — | — |
| Jun 1, 2025 | NeoGenomics Inc. | Grant or award | +12,254 | — | — |
| May 23, 2025 | Rigel Pharmaceuticals Inc. | Grant or award | +2,500 | — | — |
| Aug 10, 2024 | NeoGenomics Inc. | Option exercise | +11,336 | — | — |
| May 25, 2024 | Rigel Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
| May 26, 2023 | Rigel Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
Questions about Alison L. Hannah
What boards is Alison L. Hannah on?
Alison L. Hannah sits on the boards of NeoGenomics Inc. and Rigel Pharmaceuticals Inc.
How long has Alison L. Hannah served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.